Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Trials|September 1, 2019
Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trialLaila König, Martin Dreyling, Jan Dürig, et al.
Journal of the National Cancer Institute|October 25, 2011
Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trialsLiat Vidal, Anat Gafter-Gvili, Gilles Salles, et al.
Hematological Oncology|March 16, 2013
Sorafenib in patients with refractory or recurrent multiple myelomaAnna Yordanova, Dirk Hose, Kai Neben, et al.
Frontiers in Bioengineering and Biotechnology|March 27, 2020
Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome SequencingAayushi Srivastava, Sara Giangiobbe, Abhishek Kumar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2011
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myelomaBrigitte Neuber, Isabelle Herth, Claudia Tolliver, et al.
Journal of Clinical Apheresis|April 29, 2014
Rescue stem cell mobilization with plerixafor economizes leukapheresis in patients with multiple myelomaMichael Hundemer, Melanie Engelhardt, Thomas Bruckner, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent PrognosisKatharina Kriegsmann, Julia S Klee, Manfred Hensel, et al.
BMC Cancer|February 24, 2017
High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient settingKatharina Lisenko, Sandra Sauer, Thomas Bruckner, et al.
Cancer Investigation|September 17, 2016
Salvage Chemotherapy with R-DHAP in Patients with Relapsed or Refractory Non-Hodgkin LymphomaNadine G D Schirmbeck, Ulrich J M Mey, Attilio Olivieri, et al.
Transfusion|June 28, 2017
Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myelomaKatharina Lisenko, Marc-Andrea Baertsch, Renate Meiser, et al.
Pageof 8